Alliance A031501

Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) in muScle invaSive and locally ADvanced urOthelial caRcinoma” (AMBASSADOR) versus observation

For more information about this clinical trial, click here

Schema & Eligibility Alliance A031501

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Care Cancer Center, Bolivar, MO
Delbert Day Cancer Institute at PCRMC, Rolla, MO
Freeman Health System, Joplin, MO
Mercy Hospital, St. Louis, MO
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO

Good Samaritan Regional Health Center, Mt. Vernon, IL